- AU$65.61m
- AU$68.19m
- AU$57.90m
- 55
- 83
- 35
- 61
C2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.69 | 23.8 | 48.6 | 53.5 | 57.9 |
Cost of Revenue | |||||
Gross Profit | 2.69 | 7.38 | 20.6 | 25.1 | 29.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 13.9 | 42.1 | 59.9 | 66.1 | 69.1 |
Operating Profit | -6.16 | -18.2 | -11.4 | -12.7 | -11.2 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -5.93 | -18.5 | -12 | -12.8 | -11.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6 | -18.2 | -12.5 | -13.2 | -10.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -6 | -18.2 | -12.5 | -13.2 | -10.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6 | -18.2 | -12.5 | -13.2 | -10.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.016 | -0.029 | -0.012 | -0.011 | -0.008 |